4//SEC Filing
Kanes Stephen 4
Accession 0001562180-18-004912
CIK 0001597553other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 5:25 PM ET
Size
5.5 KB
Accession
0001562180-18-004912
Insider Transaction Report
Form 4
Kanes Stephen
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-12-07+6,600→ 6,600 totalExercise: $47.70Exp: 2027-02-06→ Common Stock (6,600 underlying)
Footnotes (1)
- [F1]On February 6, 2017, the reporting person was granted an option to purchase 20,000 shares of common stock. The option vests upon the achievement of certain milestones, one of which was met on December 7, 2018, resulting in the vesting of the option as to 6,600 shares.
Documents
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0001612859
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 5:25 PM ET
- Size
- 5.5 KB